(Press-News.org) Portland, Ore. – March 27, 2023 – Hemex Health, a medical diagnostic device company focused on expanding healthcare access to underrepresented patient populations, announced it has been awarded a 3-year, $3 million grant from the National Heart, Lung, and Blood Institute (NHLBI). NHLBI, part of the National Institutes of Health, awarded a SBIR Phase IIB Bridge Award to Hemex to advance the commercialization of the company’s Gazelle® Hb Variant Test for the United States market.
Hemex intends to use the grant to complete activities required for FDA 510(k) clearance.
The Hb Variant Test, one of the tests supported by the Gazelle diagnostic platform, can detect Sickle Cell Disease (SCD) and beta thalassemia – genetic blood disorders that can result in debilitating pain, disability, severe complications or death.
As an affordable, portable, point-of-care test, Gazelle’s results are equivalent to standard lab tests but do not require complex logistical support. Gazelle is highly accurate: previous research found that it can detect SCD with 99% accuracy. The device and cartridges are designed to be affordable for underrepresented communities, and test results appear onscreen in only eight minutes.
"An accurate point-of-care test for sickle cell disease and trait is crucial in helping address the challenges of misdiagnosis and undiagnosed patients who could potentially miss out on life saving medical care,” said Dr. Stephen Boateng, Director of Research, Sickle Cell 101, a non-profit patient group providing sickle cell education to individuals impacted by the condition in the U.S. and globally. “Such a test that can also provide results in minutes provides an additional benefit, especially during community outreach events where participants could be lost to follow up due to the length of time it might take for results to come back."
Armed with these advantages, Gazelle is helping to revolutionize the diagnosis of these disorders, having conducted hundreds of thousands of tests in 27 countries across India, Africa, the Middle East, and Southeast Asia. Gazelle is bringing highly accurate testing to low resource populations who have never had access to this level of testing.
Please click here to continue reading.
With this grant, Hemex seeks to replicate its international success and expand into the United States.
The CDC states that genetic blood disorders are most prevalent among Americans of African, Hispanic, Indian, Mediterranean, and Southeast Asian descent. The American Society of Hematology (ASH) estimates that 100,000 Americans have SCD and that up to three million are carriers, including up to 8% of African-Americans. In the US, the CDC says that SCD can decrease life expectancy by up to 20 years.
“Millions of Americans are carriers of the sickle cell trait or beta thalassemia trait, but according to research, only a small percentage know their status,” said Patti White, CEO, Hemex Health. “This test can empower people to quickly learn their status, which may impact family planning or other important decisions.”
“As we have done around the world, Hemex hopes to use our products to bring the needs of sickle cell and beta thalassemia patients into the light of day by reaching the hard-to-reach, and providing this population with the diagnoses they need to get effective treatment,” said Ms. White. “I am incredibly proud of our team and our products, and grateful to NHLBI for the opportunity they have given us to bring our work to the US.”
This work is funded by the National Heart, Lung, and Blood Institute under grant award number 2R44HL140739-04. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
About Gazelle
Gazelle is a compact, rugged, battery-operated in vitro diagnostic device. It is used inexpensively, with no cold chain requirements, by entry level healthcare workers in areas with limited access, resources, or electricity. Patient information and results are captured digitally for storage, printing, or later transmission. Gazelle is approved for detecting sickle cell disease and beta thalassemia in a growing list of countries and integrates miniaturized versions of trusted technologies, innovative optics, and artificial intelligence. This versatile approach allows the company to continually add diseases to its menu of tests and expand to new users. Gazelle is an accurate and rapid digital platform that can work about anywhere in the world – from remote, low resource settings to drive-through testing, border crossings, or nursing homes. More information about Gazelle is available at https://hemexhealth.com/products.
About Hemex
Hemex Health breaks traditional barriers with its innovative diagnostic system that expands the potential of diagnostics for important conditions, making accurate tests accessible to new locations and new populations. Hemex Health designs diagnostic technologies for the real world by listening to the needs of healthcare providers including those in some of the most remote and challenging settings. The Gazelle technology was developed in collaboration with Case Western Reserve University. Hemex Health is in Portland, Oregon, U.S.A. More information can be found at www.hemexhealth.com.
###
END
DALLAS, March 29, 2023 — New training tools from the American Heart Association will help health equity innovators address issues like structural racism and other social factors that impact health in urban and rural communities. A recent study found that Black and LatinX founders represented just 2.6% of total funding raised by venture capital in 2020.[1] In its commitment to ensuring equitable health for all, the Association supports innovators and other social enterprises, start-ups, non-profits, and digital and health tech companies that are addressing health equity challenges in their local communities with mentoring, funding opportunities and – now – ongoing ...
BOSTON, March 29, 2023 — The Institute for Protein Innovation (IPI) will host IPI Surfacing, a symposium on cell surface receptor biology, on Thursday, June 15, 2023. The free, day-long event convenes biomedical scientists at the Joseph B. Martin Conference Center at Harvard Medical School. Registration opens today.
As its inaugural symposium, IPI Surfacing reflects the Institute’s mission to advance protein science to accelerate research and improve human health. In addition to providing ...
Scientists at the Fralin Biomedical Research Institute at VTC are looking to uncover the “why” of the American diet. Why are people drawn to ultra-processed foods, which have been linked to obesity, Type 2 diabetes, different types of cancer, and increased risk of heart disease and death?
It’s a critical question because ultra-processed foods make up about 58 percent of calories consumed in the United States. These foods have been through multiple manufacturing processes and contain many added ingredients. Examples include sweetened cereals, hot dogs, chips, and soft drinks.
“We ...
INDIANAPOLIS, March 29, 2023 — Specialty coffees are gaining traction in coffeehouses around the world — and now a fermented version could bring a fruity taste to your morning cup of joe. This new kind of beverage has a raspberry-like taste and aroma, but what causes these sensations has been a mystery. Today, scientists report six compounds that contribute to the fermented coffee experience. The work could help increase production of the drink and make it more readily available for everyone to enjoy.
The researchers ...
INDIANAPOLIS, March 29, 2023 — Imagine getting the benefits of gastric bypass surgery without going under the knife — a new class of compounds could do just that. In lab animals, these potential treatments reduce weight dramatically and lower blood glucose. The injectable compounds also avoid the side effects of nausea and vomiting that are common with current weight-loss and diabetes drugs. Now, scientists report that the new treatment not only reduces eating but also boosts calorie burn.
The researchers will present their results today at the spring meeting of the American Chemical Society ...
Enzymes work in the cells of all living organisms, allowing specific and complex reactions to be carried out quite easily. However, few natural enzymes are effective for industrial applications, which could benefit greatly from discoveries that make targeted enzyme creation a reality.
Artificial metalloenzymes can be created simply by binding metal ions or metallic compounds to proteins, so that they exhibit enzymatic activity. Currently, metalloenzymes are being studied to discover new functions or improve their reactivity ...
Lizards may be small, with only a single hearing bonelet compared to our three, and without earflaps, but their hearing is typically good. Most lizards can hear frequencies between 100 and 5,000 Hz (although they are most sensitive between 400 and 1,500 Hz), compared to between 20 and 20,000 Hz in humans. So how do lizards react to noise pollution?
Here, scientists studied the impact of noise from low-flying military aircraft on the behavior and well-being of an uncommon lizard, the Colorado checkered whiptail (Aspidoscelis neotesselatus). This ...
A research group including Professors Mitsumasa Koyanagi and Akihisa Terakita of the Osaka Metropolitan University Graduate School of Science has investigated both the genetic information and structure of the photoreceptor rhodopsin, responsible for detecting dim light, of whale sharks to investigate how they can see in the dim light at extreme depths. The research group compared the whale sharks to zebra sharks, which are considered their closest relative, and brown-banded bamboo sharks, which are in the same group: the order orectolobiformes—commonly known as carpet sharks.
“This research used genetic ...
In his new book Primary Health Care and Population Mortality, released next week, Professor Richard Baker draws on international evidence to show how primary health care is key to the effect of health systems on population mortality and inequality in mortality. His conclusion is that it is time to think about primary health care in a new way.
He explains: “It is as if policymakers think primary health care is little more than a triage mechanism for the health system, that its purpose is to manage access to other ...
A team of astronomers has discovered one of the biggest black holes ever found, taking advantage of a phenomenon called gravitational lensing.
The team, led by Durham University, UK, used gravitational lensing - where a foreground galaxy bends the light from a more distant object and magnifies it – and supercomputer simulations on the DiRAC HPC facility, which enabled the team to closely examine how light is bent by a black hole inside a galaxy hundreds of millions of light years from Earth.
They found an ultramassive black hole, an object over 30 billion times the ...
